Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | ESR1 | P03372 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | CA2 | P00918 | 3/20 | 0.47 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA7 | P43166 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.47 |
| ▸ | IDO1 | P14902 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.44 |
| ▸ | KDR | P35968 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7641621 | 0.94 | ALDH1A1 (0.52) | KMT2AMEN1ALDH1A1CA2MAPK1 | |
| SCHEMBL2623828 | 0.88 | RXRA (0.47) | KMT2AMEN1ALDH1A1MAPK1L3MBTL1 | |
| SCHEMBL18087031 | 0.88 | ALDH1A1 (0.47) | KMT2AMEN1ALDH1A1MAPK1L3MBTL1 | |
| SCHEMBL3134365 | 0.86 | ALDH1A1 (0.50) | KMT2AMEN1LMNAALDH1A1MAPK1 | |
| SCHEMBL1709750 | 0.84 | ALDH1A1 (0.52) | KMT2AMEN1ALDH1A1MAPK1L3MBTL1 | |
| SCHEMBL22435386 | 0.84 | MEN1 (0.53) | KMT2AMEN1LMNAESR1ALDH1A1 | |
| SCHEMBL31211780 | 0.84 | ALDH1A1 (0.44) | KMT2AMEN1ALDH1A1CA2MAPK1 | |
| SCHEMBL10082417 | 0.84 | CYP1A2 (0.47) | KMT2AMEN1LMNAALDH1A1CA2 | |
| SCHEMBL29345026 | 0.84 | TPSAB1 (0.47) | KMT2AMEN1ALDH1A1CA2MAPK1 | |
| SCHEMBL15161585 | 0.84 | KMT2A (0.51) | KMT2AMEN1LMNAALDH1A1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110898003-A | Novel bambuterol hydrochloride oral solution and preparation method thereof | 岳阳新华达制药有限公司 | 2020-03-24 | — | — | CN | claimed |
| CN-116322328-B | Pesticide composition comprising elemental sulphur and choline salts of pelargonic acid | 希特逊库玛·阿尼凯特·多希 | 2025-05-06 | — | — | CN | disclosed |
| EP-4240313-A1 | SHAVING AID COMPRISING AN ANTIOXIDANT | The Gillette Company LLC (US) | 2023-09-13 | — | — | EP | disclosed |
| CN-114967338-A | Green photosensitive resin composition, color filter and display device manufactured by using same | 东友精细化工有限公司 | 2022-08-30 | — | — | CN | disclosed |
| EP-4019507-A1 | FIBROBLAST ACTIVATION PROTEIN LIGANDS FOR TARGETED DELIVERY APPLICATIONS | Philochem AG (CH) | 2022-06-29 | — | — | EP | disclosed |
| WO-2022098632-A1 | SHAVING AID COMPRISING AN ANTIOXIDANT | THE GILLETTE COMPANY LLC (US) | 2022-05-12 | — | — | WO | disclosed |
| CN-110898003-A | Novel bambuterol hydrochloride oral solution and preparation method thereof | 岳阳新华达制药有限公司 | 2020-03-24 | — | — | CN | disclosed |
| CN-108640834-A | The synthesis technology of esmolol intermediate 3- (4- hydroxy phenyls) methyl propionate | 湖北广辰药业有限公司 | 2018-10-12 | — | — | CN | disclosed |
| CN-107868033-A | A kind of preparation method of phenylalanine class compound | 深圳微芯生物科技有限责任公司 | 2018-04-03 | — | — | CN | disclosed |
| EP-2428577-B1 | Preparation of tyrosinase-inhibiting hydroxybenzyl and hydroxypyranonemethyl esters | EASTMAN CHEM CO (US) | 2014-01-22 | — | — | EP | disclosed |
| EP-2155886-A2 | HYDROXYBENZYL OR HYDROXYPYRANONEMETHYL ESTERS AS TYROSINASE INHIBITORS | Eastman Chemical Company (US) | 2010-02-24 | — | — | EP | disclosed |
| WO-2008153784-A2 | HYDROXYBENZYL OR HYDROXYPYRANONEMETHYL ESTERS AS TYROSINASE INHIBITORS | EASTMAN CHEMICAL COMPANY (US) | 2008-12-18 | — | — | WO | disclosed |
| US-20080306144-A1 | Hydroxybenzyl or hydroxypyranonemethyl esters as tyrosinase inhibitors | EASTMAN CHEMICAL COMPANY | 2008-12-11 | — | — | US | disclosed |
| CN-1164579-C | Thiazole and oxazole derivatives and their pharmaceutical use | — | 2004-09-01 | — | — | CN | disclosed |
| CN-1093124-C | Substituted 4-hydroxy-phenylalcanoic acid derivatives with activity to ppar-'gamma' | GLAXO GROUP LTD (GB) | 2002-10-23 | — | — | CN | disclosed |
| CN-1358179-A | Thiazole and oxazole derivatives and their pharmaceutical use | GLAXO GROUP LTD (GB) | 2002-07-10 | — | — | CN | disclosed |
| CN-1291214-A | Compositions comprising fluoropolymers and amide functional ultraviolet light absorbers | MINNESOTA MINING & MFG (US) | 2001-04-11 | — | — | CN | disclosed |
| CN-1218460-A | Substituted 4-hydroxy-phenylalcanoic acid derivatives with activity to ppar-'gamma' | GLAXO GROUP LTD (GB) | 1999-06-02 | — | — | CN | disclosed |
| US-4215137-A | 1-SUBSTITUTED PYRROLE DERIVATIVES | STERLING DRUG INC. (US) | 1980-07-29 | — | — | US | disclosed |
| US-4191656-A | Non-yellowing biocide for control of bacteria in spin finish emulsions used on nylon yarn | ALLIED CHEMICAL CORPORATION (US) | 1980-03-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080306144-A1 | Hydroxybenzyl or hydroxypyranonemethyl esters as tyrosinase inhibitors | TYR, TH, HAAO | KMT2A 2193/4885MEN1 4098/4885LMNA 2662/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.